TOKYO, Apr 20 (Pulse News Wire) – Heroz,inc. (4382.T) announced today that its board of directors held, approved a share transfer agreement to sell its subsidiary Stratejit's shares to GMO GlobalSign Holdings Co., Ltd.
The transaction is expected to close by April 30, 2026, and will result in significant changes to Stratejit’s operations. Stratejit, which specializes in iPaaS solutions such as JOINT, has been instrumental in promoting digital transformation among enterprises. By transferring Stratejit’s shares to GMO GlobalSign Holdings, HEROZ aims to leverage the strengths of GMO’s internet infrastructure and digital support services to maximize Stratejit’s technology and expertise in SaaS integration.
Key details of the deal include: - Number of shares transferred: 79,499 - Transfer price: Up to ¥424.6 million (including adjustments based on contract adherence) - Post-transfer ownership: 0 shares (0 voting rights) Stratejit reported revenue of 198 million yen for the latest fiscal year ending February 2025. As part of the agreement, HEROZ expects to realize gains from the sale but will disclose precise figures once finalized. This strategic move underscores HEROZ’s commitment to optimizing its portfolio and enhancing shareholder value through targeted divestitures.
🟡 Confidence: Standard AI-translated content.